Bupivacaine in the Treatment of Postoperative Pain of Impacted Third Molar Extraction
Status:
Completed
Trial end date:
2020-01-01
Target enrollment:
Participant gender:
Summary
The third molars are the teeth that are most frequently included and impacted, extraction is
one of the most performed treatments by maxillofacial surgeons in their clinical practice.
Its surgical extraction is accompanied by an inflammatory process, which generates pain,
edema and trismus. The use of alternatives that offer prolonged analgesia, like the use of
bupivacaine, reduce the pain of the patient after an extraction of third molars, allows the
reduction of morbidity and the rapid return to daily activities.
In addition, it allows a better experience in the dental consultation.
Investigators hypothesis is:
Irrigation of the alveolus with 4 ml of 0.5% bupivacaine is effective for the reduction of
post-operative pain in extraction of impacted lower third molars